Institution
Centre Hospitalier Universitaire Amiens-Picardie
Also known as: CHU Amiens-Picardie · CHUAP
- 273running trials
- 88closed trials
- 16,396publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
Not yet recruiting
FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Not yet recruiting
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.
Recruiting
Recruiting
Recruiting
Not yet recruiting
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
Not yet recruiting
Not yet recruiting
Reduction of treatment after Complete Response in Advanced Hormone-Sensitive Breast Cancer
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Suspended
Not yet recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
Recruiting
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis
Showing 50 of 273.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers22 recruiting
- Crohn's disease14 recruiting
- Colorectal cancer10 recruiting
- Acute myeloid leukaemia9 recruiting
- Head and neck cancer8 recruiting
- Heart failure8 recruiting
- Bronchiectasis7 recruiting
- Fatty liver disease (MASLD/MASH)7 recruiting
- Liver and biliary tract cancer7 recruiting
- Metastatic breast cancer6 recruiting
- Multiple myeloma6 recruiting
- Ulcerative colitis6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Cystic fibrosis5 recruiting
- ANCA-associated vasculitis4 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Chronic myeloid leukaemia4 recruiting
- High blood pressure4 recruiting
- Idiopathic pulmonary fibrosis4 recruiting
- Lung cancer4 recruiting
- Neuroendocrine tumours4 recruiting
- Obesity4 recruiting
- Triple-negative breast cancer4 recruiting
- Atrial fibrillation3 recruiting
- Coronary artery disease3 recruiting
- Deep vein thrombosis and pulmonary embolism3 recruiting
- Glioblastoma3 recruiting
- Liver cirrhosis3 recruiting
- Lupus (SLE)3 recruiting
- Multiple sclerosis3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Sarcoma3 recruiting
- Asthma2 recruiting
- Bladder cancer2 recruiting
- Chronic kidney disease2 recruiting
- COPD2 recruiting
- Huntington's disease2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myocarditis2 recruiting
- Ovarian cancer2 recruiting
- Parkinson disease2 recruiting
- Psoriasis2 recruiting
- Stroke2 recruiting
- Amyloidosis1 recruiting
- Aortic stenosis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Brain aneurysm1 recruiting
- Charcot-Marie-Tooth disease1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Cushing's syndrome1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometriosis1 recruiting
- Epilepsy1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Gout1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- Hidradenitis suppurativa1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- IgA nephropathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Macular degeneration1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Narcolepsy1 recruiting
- Neuroblastoma1 recruiting
- Osteoarthritis1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Osteoporosis1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Schizophrenia1 recruiting
- Sickle cell disease1 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Tuberculosis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Not yet recruiting
Recruiting
Completed
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Completed
Completed
Completed
Completed
Completed
Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7.
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Active, not recruiting
Active, not recruiting
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed
Terminated
Completed
Active, not recruiting
Completed
Completed
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Completed
Completed
Enrolling by invitation
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
Completed
Completed
Completed
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
Completed
Completed
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
Active, not recruiting
Completed
Completed
Completed
Completed
Showing 50 of 88.
Registry name variants (15)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Centre Hospitalier Universitaire Amiens Picardie
Amiens Cedex 1, 80054
220 trials
Chu Amiens Picardie
Amiens, 80000
67 trials
Centre Hospitalier Universitaire Amiens - Picardie
Amiens, 80080
57 trials
CHU Amiens-Picardie - Site Sud
Amiens, Somme 80054
10 trials
Centre Hospitalier Universitaire Amiens-Picardie - Site Sud
Amiens, Picardie 80054
4 trials
CHU Amiens-Picardie
Salouël, 80480
2 trials
NCT06634641Clozapine-related Immunodeficiency in Parkinsons Disease
Contact: Mickaël AUBIGNAT, MD
AMIENS - CHU Amiens Picardie
Amiens, 80054
1 trial
C12 - Médecine Vasculaire - CHU Amiens Picardie
Amiens, 80054
1 trial
NCT07315347Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.
Contact: Marie-Antoinette SEVESTRE-PIETRI, MD
CHU de Amiens Picardie
Amiens, 80054
1 trial
Service de Chirurgie Digestive, CHU Amiens Picardie
Amiens
1 trial
CHU Amiens-Picardie - Service d'oncologie hématologie pédiatrique
Amiens
CHU Amiens Picardie - Site Sud
Dreuil-lès-Amiens, 80470
Endoscopy: CHU Amiens-Picardie
Amiens, 80054
Pulmonary examination: CHU Amiens-Picardie
Amiens, 80054
Tomography: CHU Amiens-Picardie
Amiens, 80054
Conditions
Diseases this institution publishes on or runs trials for.
- Crohn's disease30 works · 27 trials
- Hypertrophic cardiomyopathy18 works · 1 trial
Institution data: ROR 010567a58 (CC0-1.0)Updated 14 Nov 2026